New

Immune Globulins Market

2021

Immune Globulins Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (IgG, IgA, IgM, IgE, IgD); Route of Administration (Intravenous, Subcutaneous); Application (Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Others); and Geography

| Report Code: TIPRE00021154 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Immune Globulins Market 2028 By Type, Route of Administration, Application, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Immune globulin (Ig) is a sterile solution made with human plasma which significantly provides short-term, immediate protection against measles infections and hepatitis A. Also, it reduces the risk of infection in the immunocompromised patient, who have a decreased ability to produce antibodies. Moreover, these Immune globulin (Ig) solutions are available in both powder as well as liquid form.

MARKET DYNAMICS

Increasing prevalence of blood-related diseases and exponential growth in geriatric population are actively contributing to the growth of immune globulins market. However, high cost and increased risk of side effects are expected to hamper the market growth.

MARKET SCOPE

The "Immune Globulins Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Immune Globulins Market with detailed market segmentation by type, route of administration, and application. The Immune Globulins Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Immune Globulins Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Immune Globulins Market is segmented on the basis of type, route of administration, and application. On the basis of type, the market is segmented as IgG, IgA, IgM, IgE, and IgD. Based on route of administration, the market is segmented as intravenous and subcutaneous. On the basis of application, the market is segmented as multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Immune Globulins Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Immune Globulins Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Immune Globulins Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Immune Globulins Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Immune Globulins Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Immune Globulins Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Immune Globulins Market.

The report also includes the profiles of key players in Immune Globulins Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Baxter international Inc.
  •   CSL Ltd.
  •   Octapharma AG
  •   Kedrion Biopharma Inc.
  •   LFB group
  •   Biotest AG
  •   China Biologics Products, Inc.
  •   Bayer Healthcare
  •   ADMA Biologics, Inc.
  •   BioScrip, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immune Globulins Market - By Type
1.3.2 Immune Globulins Market - By Route of Administration
1.3.3 Immune Globulins Market - By Application
1.3.4 Immune Globulins Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMMUNE GLOBULINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMMUNE GLOBULINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMMUNE GLOBULINS MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNE GLOBULINS - GLOBAL MARKET OVERVIEW
6.2. IMMUNE GLOBULINS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. IMMUNE GLOBULINS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. IGG
7.3.1. Overview
7.3.2. IgG Market Forecast and Analysis
7.4. IGA
7.4.1. Overview
7.4.2. IgA Market Forecast and Analysis
7.5. IGM
7.5.1. Overview
7.5.2. IgM Market Forecast and Analysis
7.6. IGE
7.6.1. Overview
7.6.2. IgE Market Forecast and Analysis
7.7. IGD
7.7.1. Overview
7.7.2. IgD Market Forecast and Analysis
8. IMMUNE GLOBULINS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAVENOUS
8.3.1. Overview
8.3.2. Intravenous Market Forecast and Analysis
8.4. SUBCUTANEOUS
8.4.1. Overview
8.4.2. Subcutaneous Market Forecast and Analysis
9. IMMUNE GLOBULINS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MULTIFOCAL MOTOR NEUROPATHY
9.3.1. Overview
9.3.2. Multifocal Motor Neuropathy Market Forecast and Analysis
9.4. IDIOPATHIC THROMBOCYTOPENIC PURPURA
9.4.1. Overview
9.4.2. Idiopathic Thrombocytopenic Purpura Market Forecast and Analysis
9.5. INFLAMMATORY MYOPATHIES
9.5.1. Overview
9.5.2. Inflammatory Myopathies Market Forecast and Analysis
9.6. SPECIFIC ANTIBODY DEFICIENCY
9.6.1. Overview
9.6.2. Specific Antibody Deficiency Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. IMMUNE GLOBULINS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Immune Globulins Market Overview
10.1.2 North America Immune Globulins Market Forecasts and Analysis
10.1.3 North America Immune Globulins Market Forecasts and Analysis - By Type
10.1.4 North America Immune Globulins Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Immune Globulins Market Forecasts and Analysis - By Application
10.1.6 North America Immune Globulins Market Forecasts and Analysis - By Countries
10.1.6.1 United States Immune Globulins Market
10.1.6.1.1 United States Immune Globulins Market by Type
10.1.6.1.2 United States Immune Globulins Market by Route of Administration
10.1.6.1.3 United States Immune Globulins Market by Application
10.1.6.2 Canada Immune Globulins Market
10.1.6.2.1 Canada Immune Globulins Market by Type
10.1.6.2.2 Canada Immune Globulins Market by Route of Administration
10.1.6.2.3 Canada Immune Globulins Market by Application
10.1.6.3 Mexico Immune Globulins Market
10.1.6.3.1 Mexico Immune Globulins Market by Type
10.1.6.3.2 Mexico Immune Globulins Market by Route of Administration
10.1.6.3.3 Mexico Immune Globulins Market by Application
10.2. EUROPE
10.2.1 Europe Immune Globulins Market Overview
10.2.2 Europe Immune Globulins Market Forecasts and Analysis
10.2.3 Europe Immune Globulins Market Forecasts and Analysis - By Type
10.2.4 Europe Immune Globulins Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Immune Globulins Market Forecasts and Analysis - By Application
10.2.6 Europe Immune Globulins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Immune Globulins Market
10.2.6.1.1 Germany Immune Globulins Market by Type
10.2.6.1.2 Germany Immune Globulins Market by Route of Administration
10.2.6.1.3 Germany Immune Globulins Market by Application
10.2.6.2 France Immune Globulins Market
10.2.6.2.1 France Immune Globulins Market by Type
10.2.6.2.2 France Immune Globulins Market by Route of Administration
10.2.6.2.3 France Immune Globulins Market by Application
10.2.6.3 Italy Immune Globulins Market
10.2.6.3.1 Italy Immune Globulins Market by Type
10.2.6.3.2 Italy Immune Globulins Market by Route of Administration
10.2.6.3.3 Italy Immune Globulins Market by Application
10.2.6.4 Spain Immune Globulins Market
10.2.6.4.1 Spain Immune Globulins Market by Type
10.2.6.4.2 Spain Immune Globulins Market by Route of Administration
10.2.6.4.3 Spain Immune Globulins Market by Application
10.2.6.5 United Kingdom Immune Globulins Market
10.2.6.5.1 United Kingdom Immune Globulins Market by Type
10.2.6.5.2 United Kingdom Immune Globulins Market by Route of Administration
10.2.6.5.3 United Kingdom Immune Globulins Market by Application
10.2.6.6 Rest of Europe Immune Globulins Market
10.2.6.6.1 Rest of Europe Immune Globulins Market by Type
10.2.6.6.2 Rest of Europe Immune Globulins Market by Route of Administration
10.2.6.6.3 Rest of Europe Immune Globulins Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Immune Globulins Market Overview
10.3.2 Asia-Pacific Immune Globulins Market Forecasts and Analysis
10.3.3 Asia-Pacific Immune Globulins Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Immune Globulins Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Immune Globulins Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Immune Globulins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Immune Globulins Market
10.3.6.1.1 Australia Immune Globulins Market by Type
10.3.6.1.2 Australia Immune Globulins Market by Route of Administration
10.3.6.1.3 Australia Immune Globulins Market by Application
10.3.6.2 China Immune Globulins Market
10.3.6.2.1 China Immune Globulins Market by Type
10.3.6.2.2 China Immune Globulins Market by Route of Administration
10.3.6.2.3 China Immune Globulins Market by Application
10.3.6.3 India Immune Globulins Market
10.3.6.3.1 India Immune Globulins Market by Type
10.3.6.3.2 India Immune Globulins Market by Route of Administration
10.3.6.3.3 India Immune Globulins Market by Application
10.3.6.4 Japan Immune Globulins Market
10.3.6.4.1 Japan Immune Globulins Market by Type
10.3.6.4.2 Japan Immune Globulins Market by Route of Administration
10.3.6.4.3 Japan Immune Globulins Market by Application
10.3.6.5 South Korea Immune Globulins Market
10.3.6.5.1 South Korea Immune Globulins Market by Type
10.3.6.5.2 South Korea Immune Globulins Market by Route of Administration
10.3.6.5.3 South Korea Immune Globulins Market by Application
10.3.6.6 Rest of Asia-Pacific Immune Globulins Market
10.3.6.6.1 Rest of Asia-Pacific Immune Globulins Market by Type
10.3.6.6.2 Rest of Asia-Pacific Immune Globulins Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Immune Globulins Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Immune Globulins Market Overview
10.4.2 Middle East and Africa Immune Globulins Market Forecasts and Analysis
10.4.3 Middle East and Africa Immune Globulins Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Immune Globulins Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Immune Globulins Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Immune Globulins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Immune Globulins Market
10.4.6.1.1 South Africa Immune Globulins Market by Type
10.4.6.1.2 South Africa Immune Globulins Market by Route of Administration
10.4.6.1.3 South Africa Immune Globulins Market by Application
10.4.6.2 Saudi Arabia Immune Globulins Market
10.4.6.2.1 Saudi Arabia Immune Globulins Market by Type
10.4.6.2.2 Saudi Arabia Immune Globulins Market by Route of Administration
10.4.6.2.3 Saudi Arabia Immune Globulins Market by Application
10.4.6.3 U.A.E Immune Globulins Market
10.4.6.3.1 U.A.E Immune Globulins Market by Type
10.4.6.3.2 U.A.E Immune Globulins Market by Route of Administration
10.4.6.3.3 U.A.E Immune Globulins Market by Application
10.4.6.4 Rest of Middle East and Africa Immune Globulins Market
10.4.6.4.1 Rest of Middle East and Africa Immune Globulins Market by Type
10.4.6.4.2 Rest of Middle East and Africa Immune Globulins Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Immune Globulins Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Immune Globulins Market Overview
10.5.2 South and Central America Immune Globulins Market Forecasts and Analysis
10.5.3 South and Central America Immune Globulins Market Forecasts and Analysis - By Type
10.5.4 South and Central America Immune Globulins Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Immune Globulins Market Forecasts and Analysis - By Application
10.5.6 South and Central America Immune Globulins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Immune Globulins Market
10.5.6.1.1 Brazil Immune Globulins Market by Type
10.5.6.1.2 Brazil Immune Globulins Market by Route of Administration
10.5.6.1.3 Brazil Immune Globulins Market by Application
10.5.6.2 Argentina Immune Globulins Market
10.5.6.2.1 Argentina Immune Globulins Market by Type
10.5.6.2.2 Argentina Immune Globulins Market by Route of Administration
10.5.6.2.3 Argentina Immune Globulins Market by Application
10.5.6.3 Rest of South and Central America Immune Globulins Market
10.5.6.3.1 Rest of South and Central America Immune Globulins Market by Type
10.5.6.3.2 Rest of South and Central America Immune Globulins Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Immune Globulins Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMMUNE GLOBULINS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. IMMUNE GLOBULINS MARKET, KEY COMPANY PROFILES
13.1. BAXTER INTERNATIONAL INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CSL LTD.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. OCTAPHARMA AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. KEDRION BIOPHARMA INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LFB GROUP
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BIOTEST AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CHINA BIOLOGICS PRODUCTS, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER HEALTHCARE
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ADMA BIOLOGICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOSCRIP, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Baxter international Inc.
2. CSL Ltd. Grifols S.A
3. Octapharma AG
4. Kedrion Biopharma Inc.
5. LFB group
6. Biotest AG
7. China Biologics Products, Inc.
8. Bayer Healthcare
9. ADMA Biologics, Inc.
10. BioScrip, Inc.
TIPRE00021154
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.